Paul E. Sax, MD is the Editor-in-Chief, Journal Watch HIV/AIDS Clinical Care, Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital, and Professor of Medicine at Harvard Medical School.
Learn more about HIV and ID Observations.
(5 votes, average: 3.40 out of 5)Ok, I’ll admit it — I didn’t see any studies presented at CROI this year that will immediately transform HIV care on a day-to-day basis. Nothing that will alter practice right now. Nothing like last year’s NA-ACCORD, or 2008′s surprising DAD study, or 2007′s raltegravir studies, to name a few recent examples. (All subsequently published, of course — links [...]
(22 votes, average: 3.50 out of 5)CROI just about wrapping up — excellent, as usual. Hope to provide some “greatest hits” shortly. But since John Mellors announced the dates of next year’s conference — and because the CROI web site can be “leisurely” in posting this information — I offer the following evidence as a public service to researchers, teachers, clinicians, [...]
(1 votes, average: 5.00 out of 5)Just as pitchers and catchers report to Spring Training this week, many HIV specialists are gearing up for the 17th Conference on Retroviruses and Opportunistic Infections (CROI), which starts this Tuesday in San Francisco. (I don’t suppose many people see the link between those two events. Oh well.) And since the “pocket program” to the [...]
(No Ratings Yet)It’s not on Abbott’s web site yet (update: now it’s here), but the FDA has approved a new formulation of ritonavir — a heat-stable 100 mg tablet. From an e-mail release by the FDA: On February 10, 2010, FDA approved Norvir (ritonavir) 100 mg Tablets. These tablets do not require refrigeration. Unlike the capsule formulation [...]
(1 votes, average: 5.00 out of 5)… taking antiretrovirals? Over on our Journal Watch/AIDS Clinical Care web site, we’ve posted case of a pregnant woman who says she’s taking ART as prescribed, but the lab tests say otherwise. How do you manage these cases?
(5 votes, average: 4.60 out of 5)The FDA has issued a warning about an association between use of ddI (didanosine) and the development of non-cirrhotic portal hypertension: Non-cirrhotic portal hypertension (portal hypertension that is not caused by cirrhosis of the liver) is rare in the United States. It occurs when blood flow in the major vein in the liver (the portal [...]
(3 votes, average: 5.00 out of 5)ID doctors know all too well the panicky call — usually from a terrified friend, family member, or colleague, or possibly the emergency room or primary care doc — about finding a bat in the house. Usually in the bedroom. (In one memorable case, it was the house cat’s leaping in the air to try [...]
